Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.54 |
| ▸ | NPY1R | P25929 | 8/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.54 |
| ▸ | NPY2R | P49146 | 4/20 | 0.54 |
| ▸ | BACE1 | P56817 | 2/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30866922 | 0.95 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| SCHEMBL29531412 | 0.94 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31670476 | 0.93 | BACE1 (0.53) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| SCHEMBL29666731 | 0.91 | BACE1 (0.57) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| Opiorphin (2-5) SCHEMBL30549309 | 0.90 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30272524 | 0.90 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL7645663 | 0.89 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL7645668 | 0.89 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30632623 | 0.89 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29666714 | 0.89 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |